Life

Health, science, climate, and society-focused reporting.

Briefing: Match Day results show impact of federal immigration policy

Strategic angle: In today's Morning Rounds newsletter: the high-stakes search for a new CDC director, the impact of immigration policy on budding doctors, and more.

Editorial Staff Mar 23

Life

Briefing: Doctronic raises $40 million as race to apply AI in clinical care heats up

Strategic angle: Doctronic, the startup behind a provocative experiment in Utah to renew drug prescriptions with a chatbot, has raised $40 million.

Editorial Staff Mar 23

Life

Briefing: Insmed drug benefits patients with rare, bacterial lung disease, study shows

Strategic angle: Insmed hopes to convert Arikayce's accelerated approval to a full approval.

Editorial Staff Mar 23

Life

Briefing: Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

Strategic angle: A new vaccine shows some promise in combating Lyme disease, which affects nearly half a million Americans annually.

Editorial Staff Mar 23

Life

Briefing: Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey

Strategic angle: A mother's struggle to secure a life-saving treatment for her son amidst challenges.

Editorial Staff Mar 23

Life

Briefing: Opinion: The AI push in health care is deepening medicine’s trust crisis

Strategic angle: Health care’s adoption of AI should move at the speed of trust, not investment, writes Oni Blackstock.

Editorial Staff Mar 23

Life

Briefing: The President’s Malaria Initiative and Other U.S. Government Global Malaria Efforts

Strategic angle: This fact sheet provides a snapshot of global malaria efforts and examines the U.S. government’s role in addressing malaria worldwide.

Editorial Staff Mar 23

Life

Briefing: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says

Strategic angle: The idea could be a major win for the health insurance industry, which has seen a crackdown on Medicare Advantage in recent years.

Editorial Staff Mar 20

Life

Briefing: Sepsis Hospitalizations Triple in Massachusetts: Real Concern or Billing Strategy?

Strategic angle: A significant rise in sepsis cases raises questions about the accuracy of hospital billing practices and the role of AI in medical coding.

Editorial Staff Mar 20

Life

Briefing: Inside the delicate, high-stakes search for a new CDC director

Strategic angle: Top HHS official Chris Klomp discusses the challenges of finding a new leader for the CDC.

Editorial Staff Mar 20

Life

Briefing: ACIP Conflict Tests Trump's Support for RFK Jr.'s Vaccine Policy Overhaul

Strategic angle: The Trump administration faces a pivotal decision on vaccine policymaking following a court ruling, with potential political ramifications.

Editorial Staff Mar 20

Life

Briefing: Medicare Chief Discusses TrumpRx's Narrow Focus

Strategic angle: Today's biotech news includes insights from the Medicare director on the scope of TrumpRx and the FDA's approval of high-dose Wegovy.

Editorial Staff Mar 20

Life

Briefing: STAT+: Up and down the ladder: The latest comings and goings

Strategic angle: From new hires to departures and promotions, here are the latest comings and goings in the pharmaceutical industry.

Editorial Staff Mar 20

Life

Briefing: A conversation with the ‘godfather’ of biotech

Strategic angle: This week on 'The Readout LOUD,' a conversation with biotech 'godfather' Stelios Papadapolous live from #STATBreakthrough.

Editorial Staff Mar 20

Life

Briefing: All the highlights from STAT’s Breakthrough Summit East

Strategic angle: In today's Morning Rounds newsletter, the highlights from #STATBreakthrough, a ruling against Kennedy’s gender-affirming care declaration, and more.

Editorial Staff Mar 20

Life

Briefing: Pharmalittle: Insights on TrumpRx and Wegovy

Strategic angle: Exploring expectations around TrumpRx and a new high-dose version of Wegovy.

Editorial Staff Mar 20

Life

Briefing: U.K. to Reassess Cost-Effectiveness of Alzheimer's Drugs

Strategic angle: Following successful appeals from drugmakers, the U.K. is reviewing the cost-effectiveness of two new Alzheimer's treatments.

Editorial Staff Mar 20

Life

Briefing: A family’s giving to the Broad Institute’s research tops $1 billion

Strategic angle: The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund research in the understanding and treatment of bipolar disorder and schizophrenia.

Editorial Staff Mar 20

Life

Briefing: Congress must fix the No Surprises Act before it bankrupts patients and employers

Strategic angle: James Gelfand and Patricia Kelmar argue for urgent reforms to the No Surprises Act to protect patients and employers from financial ruin.

Editorial Staff Mar 20

Life

Briefing: Tobacco could get a boost from the farm bill. How does that square with MAHA?

Strategic angle: The farm bill shows politicians catering to the agriculture industry risk losing the support of MAHA while running afoul of public health goals.

Editorial Staff Mar 20